TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment

A Phase IV, Single-blinded, Prospective, Randomized, Controlled, Multi-center Study to Compare the Clinical Outcomes of Genea Embryo Review Instrument Plus (GERI+) Time Lapse System With a Conventional Embryo Culture and Assessment System

The main purpose of the study was to evaluate the overall clinical value of GERI+ as an integrated embryo culture and assessment system, providing an undisturbed culture environment, continuous monitoring of embryo development and automated scoring using a predictive algorithm.

Inclusion Criteria:

• Couples with less than or equal to (<= ) two failed fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) embryo transfer cycles
• Age greater than or equal to (>=) 18 and <= 40 years
• Body mass index (BMI): 18-30 kilogram per meter square (kg/m2)
• Normal uterine cavity under ultrasound
• Participant and her husband/partner must have read and signed the Informed Consent form (ICF)
• At least four normally fertilized oocytes (2Pronuclear stage (PN)) in the current cycle

Exclusion Criteria:

• Male with non-ejaculated sperm
• Participants with abnormal, undiagnosed gynecological bleeding or with genitourinary malformations
• Participants with any contraindication to Controlled Ovarian Stimulation (COS) for Assisted Reproductive Technologies (ART) or to gonadotropins
• Planned "freeze all" cycle (oocytes or embryos)
• Planned preimplantation genetic screening (PGS) or Pre-implantation genetic diagnosis (PGD) cycle
• Concurrent participation in another clinical study